Commission Implementing Decision of 19 December 2011 approving certain amended programmes for the eradication and monitoring of animal diseases and zoonoses for the year 2011 and amending Decision 2010/712/EU as regards the financial contribution by the Union for programmes approved by that Decision (notified under document C(2011) 9478) (2011/862/EU)

In forceVersion 2011-12-19from 2011-12-21

Grade B

mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.

Ask Gelex about this law

Address https://gelex.eu/eli/EU/decision/2011/862@2011-12-19/en

Contents

Preamble

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Decision 2009/470/EC of 25 May 2009 on expenditure in the veterinary field, and in particular Articles 27(5) and (6) and 28(2) thereof,

Whereas:

(1) Decision 2009/470/EC lays down the procedures governing the financial contribution by the Union for programmes for the eradication, control and monitoring of animal diseases and zoonoses.

(2) Commission Decision 2008/341/EC of 25 April 2008 laying down Community criteria for national programmes for the eradication, control and monitoring of certain animal diseases and zoonoses provides that in order to be approved under the measures provided for in Article 27(1) of Decision 2009/470/EC, programmes submitted by the Member States to the Commission for the eradication, control and monitoring of the animal diseases and zoonoses listed in the Annex to that Decision must meet at least the criteria set out in the Annex to Decision 2008/341/EC.

(3) Commission Decision 2010/712/EU of 23 November 2010 approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2011 and following years approves certain national programmes and sets out the rate and maximum amount of the financial contribution by the Union for each programme submitted by the Member States.

(4) The Commission has assessed the reports submitted by the Member States on the expenditures incurred for those programmes. The results of that assessment show that certain Member States will not utilise their full allocation for the year 2011 while others will spend in excess of the allocated amount.

(5) Certain Member States have informed the Commission that, under the current financial situation, additional support to the compensation of owners of culled animals and other measures financed at a level of 50 % is required to ensure the continuity of the EU co-financed veterinary programmes, in order to maintain the positive trend regarding the different diseases.

(6) The Commission examined the requests for an increased level of funding taking into account the veterinary situation and the availability of funds from the current financial year, and considered appropriate that the eligible measures financed at a level of 50 %, receive reinforced support by modifying the level of funding to 60 %.

(7) The financial contribution by the Union for a number of national programmes therefore needs to be adjusted. It is appropriate to reallocate funding from national programmes which will not use their full allocation to those that are expected to exceed it. The reallocation should be based on the most recent information on expenditure actually incurred by the concerned Member States.

(8) In addition, Portugal has submitted an amended programme for the eradication of bovine brucellosis, Latvia has submitted an amended programme for the control of salmonellosis, Romania and Slovakia have submitted amended programmes for the control and monitoring of classical swine fever, Denmark has submitted an amended survey programme for avian influenza in poultry and wild birds, Belgium, the Czech Republic, Denmark, Germany, Estonia, Ireland, Spain, France, Italy, Cyprus, Latvia, Luxembourg, Hungary, the Netherlands, Austria, Poland, Portugal, Slovenia, Slovakia, Finland, Sweden, and the United Kingdom have submitted amended programmes for transmissible spongiform encephalopathies (TSE), bovine spongiform encephalopathy (BSE) and scrapie and Romania, Slovenia and Finland submitted amended programmes for the eradication of rabies.

(9) The Commission has assessed those amended programmes from both the veterinary and the financial point of view. They were found to comply with relevant Union veterinary legislation and in particular with the criteria set out in the Annex to Decision 2008/341/EC. The amended programmes should therefore be approved.

(10) Decision 2010/712/EU should therefore be amended accordingly.

(11) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1 Approval of amended programme for the eradication of bovine brucellosis submitted by Portugal

The amended programme for bovine brucellosis submitted by Portugal on 12 April 2011 is hereby approved for the period from 1 January 2011 to 31 December 2011.

Article 2 Approval of amended programmes for salmonellosis (zoonotic salmonella) in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) submitted by Belgium and Latvia

The following amended programmes for the control of certain zoonotic salmonella in breeding, laying and broiler flocks of Gallus gallus and in flocks of turkeys (Meleagris gallopavo) are is hereby approved for the period from 1 January 2011 to 31 December 2011:

(a) the programme submitted by Belgium on 26 July 2011;

(b) the programme submitted by Latvia on 8 March 2011.

Article 3 Approval of amended programme for classical swine fever programmes submitted by Romania and Slovakia

The following amended programmes for the control and monitoring of classical swine fever are hereby approved for the period from 1 January 2011 to 31 December 2011:

(a) the programme submitted by Romania on 7 October 2011;

(b) the programme submitted by Slovakia on 21 November 2011.

Article 4 Approval of amended survey programme for avian influenza in poultry and wild birds submitted by Denmark

The amended survey programme for avian influenza in poultry and wild birds submitted by Denmark on 4 March 2011 is hereby approved for the period from 1 January 2011 to 31 December 2011.

Article 5 Approval of amended programmes for transmissible spongiform encephalopathies (TSE), bovine spongiform encephalopathy (BSE) and scrapie submitted by certain Member States

The following amended programmes for the monitoring of transmissible spongiform encephalopathies (TSE), and for the eradication of bovine spongiform encephalopathy (BSE) and of scrapie are hereby approved for the period from 1 January 2011 to 31 December 2011:

(a) the programme submitted by Belgium on 15 June 2011;

(b) the programme submitted by the Czech Republic on 17 June 2011;

(d) the programme submitted by Germany on 14 June 2011;

(e) the programme submitted by Estonia on 27 June 2011;

(f) the programme submitted by Ireland on 29 June 2011;

(g) the programme submitted by Spain on 1 July 2011;

(h) the programme submitted by France on 13 July 2011;

(i) the programme submitted by for Italy on 22 June 2011;

(j) the programme submitted by Cyprus on 30 June 2011;

(k) the programme submitted by Latvia on 28 June 2011;

(l) the programme submitted by Luxembourg on 24 June 2011;

(m) the programme submitted by Hungary on 29 June 2011;

(n) the programme submitted by the Netherlands on 30 June 2011;

(o) the programme submitted by Austria on 29 June 2011;

(p) the programme submitted by Poland on 28 June 2011;

(q) the programme submitted by Portugal on 29 June 2011;

(r) the programme submitted by Slovenia on 8 June 2011;

(s) the programme submitted by Slovakia on 30 June 2011;

(t) the programme submitted by Finland on 22 June 2011;

(u) the programme submitted by Sweden on 20 June 2011;

(v) the programme submitted by the United Kingdom on 28 June 2011.

Article 6 Approval of amended programmes for rabies submitted by Romania and Finland

The following amended programmes for rabies are hereby approved for the period from 1 January 2011 to 31 December 2011:

(a) the programme submitted by Romania on 23 September 2011;

(b) the programme submitted by Finland on 15 September 2011.

Article 7 Approval of amended multiannual programme for rabies submitted by Slovenia

The amended multiannual programme for rabies submitted by Slovenia on 16 September 2011 is hereby approved for the period from 1 January 2011 to 31 December 2012.

Article 8 Amendments to Decision 2010/712/EU

Decision 2010/712/EU is amended as follows:

1. Article 1 is amended as follows:

(a) in paragraph 2(b), 50 % is replaced by 60 %;

(b) paragraph 2(c) is replaced by the following:

(i) EUR 4600000 for Spain;

(ii) EUR 3000000 for Italy;

(iii) EUR 90000 for Cyprus;

(iv) EUR 1040000 for Portugal;

(v) EUR 1350000 for the United Kingdom.;

(c) in paragraph 3, points (a) to (d) are replaced by the following: (a) for a rose bengal test EUR 0,24 per test; (b) for a SAT test EUR 0,24 per test; (c) for a complement fixation test EUR 0,48 per test; (d) for an ELISA test EUR 1,2 per test;

2. Article 2 is amended as follows:

(a) in paragraph 2(b), 50 % is replaced by 60 %;

(b) paragraph 2(c) is replaced by the following:

(i) EUR 16000000 for Ireland;

(ii) EUR 18500000 for Spain;

(iii) EUR 5500000 for Italy;

(iv) EUR 1440000 for Portugal;

(v) EUR 26500000 for the United Kingdom.;

(c) in paragraph 3, points (a) and (b) are replaced by the following: (a) for a tuberculin test EUR 2,4 per test; (b) for a gamma-interferon test EUR 6 per test;

3. Article 3 is amended as follows:

(a) in paragraph 2(b), 50 % is replaced by 60 %;

(b) paragraph 2(c) is replaced by the following:

(i) EUR 160000 for Greece;

(ii) EUR 9200000 for Spain;

(iii) EUR 4200000 for Italy;

(iv) EUR 85000 for Cyprus;

(v) EUR 2260000 for Portugal.;

(c) in paragraph 3, points (a) and (b) are replaced by the following: (a) for a rose bengal test EUR 0,24 per test; (b) for a complement fixation test EUR 0,48 per test;;

4. Article 4 is amended as follows:

(a) in paragraph 2(b), 50 % is replaced by 60 %;

(b) paragraph 2(c) is replaced by the following:

(i) EUR 420000 for Belgium;

(ii) EUR 10000 for Bulgaria;

(iii) EUR 1700000 for the Czech Republic;

(iv) EUR 0 for Denmark;

(v) EUR 400000 for Germany;

(vi) EUR 10000 for Estonia;

(vii) EUR 10000 for Ireland;

(viii) EUR 100000 for Greece;

(ix) EUR 5200000 for Spain;

(x) EUR 3000000 for France;

(xi) EUR 300000 for Italy;

(xii) EUR 20000 for Latvia;

(xiii) EUR 5000 for Lithuania;

(xiv) EUR 60000 for Hungary;

(xv) EUR 10000 for Malta;

(xvi) EUR 50000 for the Netherlands;

(xvii) EUR 160000 for Austria;

(xviii) EUR 50000 for Poland;

(xix) EUR 1650000 for Portugal;

(xx) EUR 100000 for Romania;

(xxi) EUR 50000 for Slovenia;

(xxii) EUR 60000 for Slovakia;

(xxiii) EUR 20000 for Finland;

(xxiv) EUR 20000 for Sweden.;

(c) in paragraph 3, points (a) to (f) are replaced by the following: (a) for an ELISA test EUR 3 per test; (b) for a PCR test EUR 12 per test; (c) for the purchase of monovalent vaccines EUR 0,36 per dose; (d) for the purchase of bivalent vaccines EUR 0,54 per dose; (e) for the administration of vaccines to bovine animals EUR 1,80 per bovine animal vaccinated, regardless of the number and types of doses used; (f) for the administration of vaccines to ovine or caprine animals EUR 0,90 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.;

5. Article 5 is amended as follows:

(a) in paragraph 2(b), 50 % is replaced by 60 %;

(b) paragraph 2(c) is replaced by the following:

(i) EUR 1200000 for Belgium;

(ii) EUR 25000 for Bulgaria;

(iii) EUR 2100000 for the Czech Republic;

(iv) EUR 340000 for Denmark;

(v) EUR 1000000 for Germany;

(vi) EUR 40000 for Estonia;

(vii) EUR 120000 for Ireland;

(viii) EUR 1000000 for Greece;

(ix) EUR 1300000 for Spain;

(x) EUR 660000 for France;

(xi) EUR 1700000 for Italy;

(xii) EUR 150000 for Cyprus;

(xiii) EUR 1650000 for Latvia;

(xiv) EUR 20000 for Luxembourg;

(xv) EUR 2400000 for Hungary;

(xvi) EUR 150000 for Malta;

(xvii) EUR 3900000 for the Netherlands;

(xviii) EUR 1200000 for Austria;

(xix) EUR 4800000 for Poland;

(xx) EUR 65000 for Portugal;

(xxi) EUR 500000 for Romania;

(xxii) EUR 120000 for Slovenia;

(xxiii) EUR 600000 for Slovakia;

(xxiv) EUR 75000 for the United Kingdom.;

(c) in paragraph 3, points (a) to (e) are replaced by the following: (a) for a bacteriological test (cultivation/isolation) EUR 8,4 per test; (b) for the purchase of vaccine EUR 0,06 per dose; (c) for serotyping of relevant isolates of Salmonella spp. EUR 24 per test; (d) for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flock EUR 6 per test; (e) for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella EUR 6 per test.;

6. Article 6 is amended as follows:

(a) in paragraph 2(b), 50 % is replaced by 60 %;

(b) paragraph 2(c) is replaced by the following:

(i) EUR 120000 for Bulgaria;

(ii) EUR 1600000 for Germany;

(iii) EUR 240000 for France;

(iv) EUR 160000 for Italy;

(v) EUR 700000 for Hungary;

(vi) EUR 700000 for Romania;

(vii) EUR 30000 for Slovenia;

(viii) EUR 300000 for Slovakia.;

7. Article 8 is amended as follows:

(a) in paragraph 2(b), 50 % is replaced by 60 %;

(b) paragraph 2(c) is replaced by the following:

(i) EUR 90000 for Belgium;

(ii) EUR 25000 for Bulgaria;

(iii) EUR 70000 for the Czech Republic;

(iv) EUR 80000 for Denmark;

(v) EUR 300000 for Germany;

(vi) EUR 10000 for Estonia;

(vii) EUR 75000 for Ireland;

(viii) EUR 50000 for Greece;

(ix) EUR 150000 for Spain;

(x) EUR 150000 for France;

(xi) EUR 1000000 for Italy;

(xii) EUR 20000 for Cyprus;

(xiii) EUR 45000 for Latvia;

(xiv) EUR 10000 for Lithuania;

(xv) EUR 10000 for Luxembourg;

(xvi) EUR 360000 for Hungary

(xvii) EUR 20000 for Malta;

(xviii) EUR 360000 for the Netherlands;

(xix) EUR 60000 for Austria;

(xx) EUR 100000 for Poland;

(xxi) EUR 45000 for Portugal;

(xxii) EUR 180000 for Romania;

(xxiii) EUR 50000 for Slovenia;

(xxiv) EUR 15000 for Slovakia;

(xxv) EUR 25000 for Finland;

(xxvi) EUR 50000 for Sweden;

(xxvii) EUR 160000 for the United Kingdom.;

(c) in paragraph 3, points (a) to (e) are replaced by the following: (a) ELISA test EUR 2,4 per test; (b) agar gel immune diffusion test EUR 1,44 per test; (c) HI test for H5/H7 EUR 14,40 per test; (d) virus isolation test EUR 48 per test; (e) PCR test EUR 24 per test.;

8. Article 9 is amended as follows:

(a) in paragraph 2(c), 50 % is replaced by 60 %;

(b) paragraph 2(d) is replaced by the following:

(d) shall not exceed the following:

(i) EUR 1900000 for Belgium;

(ii) EUR 330000 for Bulgaria;

(iii) EUR 1030000 for the Czech Republic;

(iv) EUR 1370000 for Denmark;

(v) EUR 7750000 for Germany;

(vi) EUR 330000 for Estonia;

(vii) EUR 4000000 for Ireland;

(viii) EUR 2000000 for Greece;

(ix) EUR 6650000 for Spain;

(x) EUR 18850000 for France;

(xi) EUR 6000000 for Italy;

(xii) EUR 1700000 for Cyprus;

(xiii) EUR 320000 for Latvia;

(xiv) EUR 720000 for Lithuania;

(xv) EUR 125000 for Luxembourg;

(xvi) EUR 1180000 for Hungary;

(xvii) EUR 25000 for Malta;

(xviii) EUR 3530000 for the Netherlands;

(xix) EUR 1800000 for Austria;

(xx) EUR 3440000 for Poland;

(xxi) EUR 1800000 for Portugal;

(xxii) EUR 1000000 for Romania;

(xxiii) EUR 250000 for Slovenia;

(xxiv) EUR 550000 for Slovakia;

(xxv) EUR 580000 for Finland;

(xxvi) EUR 850000 for Sweden;

(xxvii) EUR 6500000 for the United Kingdom.;

9. Article 10, paragraph 2(c) is amended as follows:

(a) in point (i) EUR 1800000 is replaced by EUR 850000;

(b) in point (ii) EUR 620000 is replaced by EUR 570000;

(d) in point (v) EUR 5000000 is replaced by EUR 2100000;

(e) in point (vii) EUR 200000 is replaced by EUR 290000;

10. in Article 10 paragraph 4, paragraphs 2 and 3 is replaced by paragraph 2(a), paragraph 2(b) and paragraph 3;

11. Article 11, paragraph 5(c) is amended as follows:

(a) in point (i) EUR 2250000 is replaced by EUR 1600000;

(b) in point (ii) EUR 1800000 is replaced by EUR 1500000;

12. in Article 11 paragraph 7, paragraphs 5 and 6 is replaced by paragraph 5(a), paragraph 5(b) and paragraph 6.

Article 9 Addressees

This Decision is addressed to the Member States.

Done at Brussels, 19 December 2011. For the Commission John Dalli Member of the Commission

Versions

2011-12-19